General Announcement::Glenmark unlocks the treatment for Mild to Moderate Covid-19 in India

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Jun-2020 17:52:14
Status
New
Announcement Sub Title
Glenmark unlocks the treatment for Mild to Moderate Covid-19 in India
Announcement Reference
SG200620OTHR2YND
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below)
Glenmark unlocks the treatment for Mild to Moderate Covid-19 in India

Attachments

SGX_PRESENTATION_20062020.pdf
Total size =2439K